Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics ...

Readers discuss an essay about whether it is a disease and how it should be diagnosed. Also: Fear in schools; natural ...

A clear FDA public education campaign could help shoppers make healthier choices. But it should first pay attention to the ...

Obesity—the bad word everyone throws around, but few want to truly understand. The American Academy of Pediatricians thought ...

Rivus already announced in August that the trial hit its key endpoint, but today fleshed out that win with some figures.

September marks National Childhood Obesity Awareness Month in the U.S., addressing the health issue that affects 1 in 5 ...

At least 1 in 5 adults in each U.S. state live with obesity, new data from the Centers for Disease Control and Prevention ...

Roche focuses on obesity drug development, fast-tracking its CT-388 candidate, and targeting $3.6 billion in annual sales.

Analyst Michael Ulz of Morgan Stanley maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), retaining the price target ...

More than a quarter of Year 6 school pupils in a borough are obese according to a new report, with the rate more than ...

WASHINGTON (DC News Now) –September has been dubbed National Childhood Obesity Awareness Month. Childhood obesity is ...

For patients with obesity, type 2 diabetes, and estimated glomerular filtration rate (eGFR) 20 to 60 mL/min/1.73 m2, metabolic surgery is associated with a lower risk for progression of kidney ...